These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24242192)

  • 1. A model for small heat shock protein inhibition of polyglutamine aggregation.
    Healy EF; Little C; King PJ
    Cell Biochem Biophys; 2014 Jun; 69(2):275-81. PubMed ID: 24242192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation.
    Robertson AL; Headey SJ; Saunders HM; Ecroyd H; Scanlon MJ; Carver JA; Bottomley SP
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10424-9. PubMed ID: 20484674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
    Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
    Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The small heat-shock protein αB-crystallin uses different mechanisms of chaperone action to prevent the amorphous versus fibrillar aggregation of α-lactalbumin.
    Kulig M; Ecroyd H
    Biochem J; 2012 Dec; 448(3):343-52. PubMed ID: 23005341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel polyglutamine model uncouples proteotoxicity from aging.
    Christie NT; Lee AL; Fay HG; Gray AA; Kikis EA
    PLoS One; 2014; 9(5):e96835. PubMed ID: 24817148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Cu2+-mediated generation of reactive oxygen species by the small heat shock protein αB-crystallin: the relative contributions of the N- and C-terminal domains.
    Prabhu S; Srinivas V; Ramakrishna T; Raman B; Rao ChM
    Free Radic Biol Med; 2011 Aug; 51(3):755-62. PubMed ID: 21658443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of αB-crystallin on protein aggregation in Drosophila.
    Tue NT; Shimaji K; Tanaka N; Yamaguchi M
    J Biomed Biotechnol; 2012; 2012():252049. PubMed ID: 22505806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
    Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
    Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of indole and a synthetic derivative for polyQ aggregation reduction by enhancement of the chaperone and autophagy systems.
    Lin CH; Wu YR; Kung PJ; Chen WL; Lee LC; Lin TH; Chao CY; Chen CM; Chang KH; Janreddy D; Lee-Chen GJ; Yao CF
    ACS Chem Neurosci; 2014 Oct; 5(10):1063-74. PubMed ID: 25197952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.
    Kvam E; Nannenga BL; Wang MS; Jia Z; Sierks MR; Messer A
    PLoS One; 2009 May; 4(5):e5727. PubMed ID: 19492089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant.
    Ahmad MF; Raman B; Ramakrishna T; Rao ChM
    J Mol Biol; 2008 Jan; 375(4):1040-51. PubMed ID: 18061612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.
    Vos MJ; Zijlstra MP; Kanon B; van Waarde-Verhagen MA; Brunt ER; Oosterveld-Hut HM; Carra S; Sibon OC; Kampinga HH
    Hum Mol Genet; 2010 Dec; 19(23):4677-93. PubMed ID: 20843828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced molecular chaperone activity of the small heat-shock protein alphaB-cystallin following covalent immobilization onto a solid-phase support.
    Garvey M; Griesser SS; Griesser HJ; Thierry B; Nussio MR; Shapter JG; Ecroyd H; Giorgetti S; Bellotti V; Gerrard JA; Carver JA
    Biopolymers; 2011 Jun; 95(6):376-89. PubMed ID: 21225714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
    Matos CA; de Macedo-Ribeiro S; Carvalho AL
    Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherent aggregation propensity of flanking residues attached to polyglutamines: implication to aggregation inhibition.
    Ghosh KS
    Protein Pept Lett; 2013 May; 20(5):569-72. PubMed ID: 23033856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.
    Chai Y; Koppenhafer SL; Bonini NM; Paulson HL
    J Neurosci; 1999 Dec; 19(23):10338-47. PubMed ID: 10575031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions as a survival strategy against abnormal aggregation.
    Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
    FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major role for side-chain polyglutamine hydrogen bonding in irreversible ataxin-3 aggregation.
    Natalello A; Frana AM; Relini A; Apicella A; Invernizzi G; Casari C; Gliozzi A; Doglia SM; Tortora P; Regonesi ME
    PLoS One; 2011 Apr; 6(4):e18789. PubMed ID: 21533208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Cu2+ binding, redox silencing, and cytoprotective effects of the small heat shock proteins alphaA- and alphaB-crystallin.
    Ahmad MF; Singh D; Taiyab A; Ramakrishna T; Raman B; Rao ChM
    J Mol Biol; 2008 Oct; 382(3):812-24. PubMed ID: 18692065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.